Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 480 | 254 |
|
Invitae United States | 75 | 72 |
|
Invitae Broad Carrier Screen without X-linked Disorders Invitae United States | 195 | 98 |
|
Invitae United States | 224 | 112 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
CPT2 - Carnitine Palmitoyltransferase deficiency type II Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 3 | 1 |
|
Carnitine Palmitoyltransferase II Deficiency via the CPT2 Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel PreventionGenetics, part of Exact Sciences United States | 106 | 83 |
|
Invitae Metabolic Newborn Screening Confirmation Panel Invitae United States | 201 | 158 |
|
Invitae Comprehensive Myopathy Panel Invitae United States | 143 | 70 |
|
Invitae Fatty Acid Oxidation Defects Panel Invitae United States | 28 | 25 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Invitae United States | 353 | 208 |
|
Invitae Dilated Cardiomyopathy and Left Ventricular Noncompaction Panel Invitae United States | 134 | 54 |
|
Invitae Cardiomyopathy Comprehensive Panel Invitae United States | 198 | 82 |
|
Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel Invitae United States | 239 | 100 |
|
Invitae Hypertrophic Cardiomyopathy Panel Invitae United States | 69 | 30 |
|
Fatty Acid Oxidation Panel (MitomeNGS) Baylor Genetics United States | 16 | 17 |
|
CPT2 Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 4 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.